Virpax Pharmaceuticals Inc (VRPX)

Virpax Pharmaceuticals Inc (VRPX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $248; returns 1 day +0.0%.

Virpax Pharmaceuticals Inc. (VRPX) is a preclinical-stage biopharmaceutical company focused on developing a pipeline of non-opioid, non-addictive treatments for pain management, central nervous system (CNS) disorders, post-traumatic stress disorder, and anti-viral barrier indications.

Groups VRPX belongs to

• Biopharmaceutical
• Pain Management
• Preclinical Development
• CNS Disorders
• Healthcare
• Biotechnology
• Clinical Stage
• Rare Diseases

VRPX financial model: income statement, cash flow and balance sheet